HomeVRPX • NASDAQ
add
Virpax Pharmaceuticals Inc
Previous close
$0.45
Day range
$0.43 - $0.45
Year range
$0.36 - $5.48
Market cap
3.50M USD
Avg Volume
6.38M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.92M | -68.53% |
Net income | -2.01M | 66.53% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.23K | -99.86% |
Total assets | 304.16K | -97.67% |
Total liabilities | 2.36M | -63.94% |
Total equity | -2.05M | — |
Shares outstanding | 4.89M | — |
Price to book | -1.07 | — |
Return on assets | -332.38% | — |
Return on capital | 198.55% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.01M | 66.53% |
Cash from operations | -4.47M | -68.59% |
Cash from investing | — | — |
Cash from financing | 2.62M | — |
Net change in cash | -1.85M | 30.08% |
Free cash flow | -3.87M | -709.83% |
About
Founded
2016
Headquarters
Website
Employees
7
